gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · BFRIWHealthcarePharmaceuticals

Biofrontera Inc. Warrants (BFRIW)

$0.0135−32.50%
Close Sep 28, 2026 · split-adjusted
Sep 28, 2026$0.01▼ 86.88% in range
Oct 7, 2025Low $0.01 · High $0.11Sep 28, 2026
What changed · written from our data
As of Sep 28, 2026

Biofrontera Inc. Warrants closed at $0.01 on Sep 28, down 32.50%, within 0.0% of its lowest close since Oct 29. Volume of 196 shares was 0.05× its 20-day average (below normal).

Split-adjusted performance: -52.5% over one month, -66.5% over six months.

In the quarter ended Jun 30, 2026, revenue was $12M, up 32.9% from a year earlier, with a net margin of -5.0%.

Short interest was 3.6K shares at the Sep 15 settlement, down 31.7% from the prior report (1.0 days to cover).

Market cap$20.1K1.5M shares
Revenue · quarter$12.0M+32.9% YoY
Diluted EPS$-0.05—
P/E · TTM—P/S 0.0×
Net margin-5.0%Gross 79.9%
Dividend yieldNone
Range since Oct 290.01 – 0.11−87.8% from high
Volume1960.05× 20-day avg
Volatility · 60d309.7%Annualised
Short % of float—1.0 days to cover
Net cash$47.0KCash $4.7M
Next earnings—Not scheduled
Split-adjusted performance
1W −34.5%1M −52.5%3M −39.2%6M −66.5%YTD −85.0%1Y —3Y −65.4%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 423 companies (100 = best)

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Industry medians: 6-month return −2.9%, revenue growth +6.4%, net margin −42.6%, P/E 16.2×.

Short interest

Details →
Shares short3.6K−31.7% vs prior
Days to cover1.0Settled Sep 15
% of float—
Short vol. 10d72.1%of daily volume

Closest peers by size in Pharmaceuticals

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
BFRIWBiofrontera Inc. Warrants$0.0135−32.50%−66.5%+32.9%−5.0%—$20.1K
SBFMWSunshine Biopharma Inc. warrant$0.0540+74.19%−61.4%−1.6%−16.9%—$165.4KCompare
BFRGWBullfrog AI Holdings, Inc. Warrants$0.1535−19.21%−9.7%+547.6%−636.8%—$202.3KCompare
MDCXWMedicus Pharma Ltd. Warrant$0.3100−12.68%−44.7%———$305.5KCompare
ASBPWAspire-Lakewood Holdings, Inc. Warrant$0.0133−32.83%−9.5%—−2009.6%—$159.32Compare
NAMSWNewAmsterdam Pharma Company N.V. Warrant$11.40−0.78%—−80.7%−1732.9%—$52.4MCompare

News about Biofrontera Inc. Warrants

All news →
Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026GlobeNewswire Inc. · May 8, 2026Neutral

Quick answers

What does Biofrontera Inc. Warrants do?
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
What is BFRIW's market cap?
$20.15K, based on the Sep 28 close of $0.01.
What sector is BFRIW in?
Healthcare, in the Pharmaceuticals industry.

About Biofrontera Inc. Warrants

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

HQ: Woburn, MA94 employeesListed Oct 29, 2021biofrontera-us.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology